Annual Operating Expenses
$9.38 M
+$120.80 K+1.30%
December 31, 2023
Summary
- As of February 7, 2025, QNRX annual total operating expenses is $9.38 million, with the most recent change of +$120.80 thousand (+1.30%) on December 31, 2023.
- During the last 3 years, QNRX annual operating expenses has risen by +$7.71 million (+461.59%).
- QNRX annual operating expenses is now at all-time high.
Performance
QNRX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$2.53 M
+$390.90 K+18.29%
September 30, 2024
Summary
- As of February 7, 2025, QNRX quarterly total operating expenses is $2.53 million, with the most recent change of +$390.90 thousand (+18.29%) on September 30, 2024.
- Over the past year, QNRX quarterly operating expenses has increased by +$69.70 thousand (+2.84%).
- QNRX quarterly operating expenses is now -15.21% below its all-time high of $2.98 million, reached on December 1, 2021.
Performance
QNRX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
QNRX Operating Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +1.3% | +2.8% |
3 y3 years | +461.6% | -8.9% |
5 y5 years | +501.0% | -8.9% |
QNRX Operating Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +54.7% | -15.2% | +21.2% |
5 y | 5-year | at high | +501.0% | -15.2% | +670.5% |
alltime | all time | at high | +501.0% | -15.2% | +670.5% |
Quoin Pharmaceuticals Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $2.53 M(+18.3%) |
Jun 2024 | - | $2.14 M(-13.1%) |
Mar 2024 | - | $2.46 M(+10.8%) |
Dec 2023 | $9.38 M(+1.3%) | $2.22 M(+4.4%) |
Sep 2023 | - | $2.13 M(-6.0%) |
Jun 2023 | - | $2.26 M(-18.6%) |
Mar 2023 | - | $2.78 M(+33.1%) |
Dec 2022 | $9.26 M | $2.09 M(-10.4%) |
Sep 2022 | - | $2.33 M(-12.8%) |
Jun 2022 | - | $2.67 M(+22.6%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $2.18 M(-27.0%) |
Dec 2021 | $6.06 M(+263.0%) | - |
Dec 2021 | - | $2.98 M(+128.8%) |
Sep 2021 | - | $1.30 M(+33.4%) |
Jun 2021 | - | $976.90 K(+21.8%) |
Mar 2021 | - | $801.80 K(+35.2%) |
Dec 2020 | $1.67 M(+7.0%) | - |
Dec 2020 | - | $592.90 K(+80.7%) |
Sep 2020 | - | $328.10 K(-6.3%) |
Jun 2020 | - | $350.20 K |
Dec 2019 | $1.56 M | - |
FAQ
- What is Quoin Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Quoin Pharmaceuticals?
- What is Quoin Pharmaceuticals annual operating expenses year-on-year change?
- What is Quoin Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Quoin Pharmaceuticals?
- What is Quoin Pharmaceuticals quarterly operating expenses year-on-year change?
What is Quoin Pharmaceuticals annual total operating expenses?
The current annual operating expenses of QNRX is $9.38 M
What is the all time high annual operating expenses for Quoin Pharmaceuticals?
Quoin Pharmaceuticals all-time high annual total operating expenses is $9.38 M
What is Quoin Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, QNRX annual total operating expenses has changed by +$120.80 K (+1.30%)
What is Quoin Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of QNRX is $2.53 M
What is the all time high quarterly operating expenses for Quoin Pharmaceuticals?
Quoin Pharmaceuticals all-time high quarterly total operating expenses is $2.98 M
What is Quoin Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, QNRX quarterly total operating expenses has changed by +$69.70 K (+2.84%)